Thymic Stromal Lymphopoietin Blocker [EPC]

Thymic Stromal Lymphopoietin Blocker [EPC] was reported 6931 times

Drugs of the Thymic Stromal Lymphopoietin Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PUVA 5 0.6250
1 HEAT THERAPY 5 0.4167
2 EAR IRRIGATION 5 0.2083
3 FRACTIONAL EXHALED NITRIC OXIDE ABNORMAL 2 0.1111
4 INFECTIVE EXACERBATION OF ASTHMA 3 0.0577
5 AIR IN DEVICE ISSUE 2 0.0465
6 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 6 0.0335
7 BLOOD IMMUNOGLOBULIN E DECREASED 5 0.0311
8 BODY TEMPERATURE 8 0.0299
9 TRIGGER POINTS 3 0.0286
10 CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 3 0.0203
11 OBSTRUCTIVE SLEEP APNOEA SYNDROME 27 0.0185
12 TRACHEOMALACIA 7 0.0177
13 NEONATAL INFECTION 6 0.0173
14 NASAL TURBINATE HYPERTROPHY 5 0.0133
15 DISCONTINUED PRODUCT ADMINISTERED 4 0.0122
16 BLOOD GLUCOSE 2 0.0113
17 EXPOSURE TO EXTREME TEMPERATURE 2 0.0103
18 PNEUMONIA PSEUDOMONAL 15 0.0098
19 ASTHMA 1067 0.0094
20 ANALGESIC THERAPY 3 0.0093
21 PEAK EXPIRATORY FLOW RATE DECREASED 4 0.0091
22 BRONCHOSCOPY 2 0.0084
23 TYPE V HYPERLIPIDAEMIA 4 0.0082
24 DYSPNOEA PAROXYSMAL NOCTURNAL 6 0.0082
25 PATIENT ELOPEMENT 3 0.0082
26 POST-ACUTE COVID-19 SYNDROME 10 0.0081
27 PRODUCT LEAKAGE 41 0.0073
28 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 3 0.0070
29 RHINITIS ALLERGIC 31 0.0070
30 REFLUX LARYNGITIS 3 0.0068
31 INFECTIVE EXACERBATION OF BRONCHIECTASIS 2 0.0065
32 INJECTION RELATED REACTION 10 0.0061
33 TONGUE PRURITUS 5 0.0058
34 CHRONIC LEFT VENTRICULAR FAILURE 2 0.0056
35 LARYNGEAL DISORDER 4 0.0055
36 PRODUCT TEMPERATURE EXCURSION ISSUE 28 0.0054
37 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 5 0.0054
38 NASAL POLYPS 26 0.0053
39 BUTTERFLY RASH 5 0.0049
40 RESPIRATORY TRACT IRRITATION 5 0.0048
41 CORNEAL DYSTROPHY 2 0.0048
42 SNORING 18 0.0048
43 PNEUMONIA NECROTISING 3 0.0046
44 DEVICE LEAKAGE 199 0.0046
45 MITE ALLERGY 3 0.0046
46 DRUG DELIVERY SYSTEM ISSUE 9 0.0046
47 BLOOD IMMUNOGLOBULIN E INCREASED 11 0.0045
48 INFUSION SITE URTICARIA 3 0.0045
49 ALLERGY TO PLANTS 2 0.0044
50 ALLERGY TO ARTHROPOD STING 2 0.0044
51 ADMINISTRATION SITE PAIN 5 0.0043
52 IMMUNOGLOBULINS INCREASED 2 0.0043
53 FACIAL DISCOMFORT 3 0.0042
54 IMPAIRED QUALITY OF LIFE 59 0.0041
55 CONJUNCTIVITIS ALLERGIC 6 0.0040
56 VITAMIN B COMPLEX DEFICIENCY 3 0.0040
57 INFECTION PARASITIC 3 0.0038
58 EOSINOPHIL COUNT INCREASED 32 0.0038
59 METAPNEUMOVIRUS INFECTION 3 0.0038
60 DEVICE DELIVERY SYSTEM ISSUE 103 0.0038
61 INCORRECT DOSE ADMINISTERED BY PRODUCT 6 0.0037
62 QUALITY OF LIFE DECREASED 47 0.0035
63 GENERALISED ANXIETY DISORDER 5 0.0034
64 DEVICE USE ISSUE 58 0.0033
65 ALLERGY TO METALS 2 0.0033
66 FAT NECROSIS 2 0.0033
67 ESSENTIAL HYPERTENSION 6 0.0033
68 BRONCHIECTASIS 22 0.0033
69 ATYPICAL FRACTURE 2 0.0032
70 PULMONARY FUNCTION TEST DECREASED 14 0.0032
71 NASAL PRURITUS 4 0.0032
72 INJECTION SITE DISCHARGE 17 0.0032
73 BRONCHIAL SECRETION RETENTION 4 0.0031
74 NOCTURNAL DYSPNOEA 4 0.0031
75 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
76 PULMONARY PAIN 9 0.0031
77 HERPES OPHTHALMIC 4 0.0030
78 ASTHMATIC CRISIS 11 0.0030
79 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 6 0.0029
80 RHONCHI 4 0.0029
81 TREATMENT DELAYED 5 0.0029
82 MAST CELL ACTIVATION SYNDROME 4 0.0028
83 INFUSION SITE DISCHARGE 5 0.0028
84 WHEEZING 169 0.0028
85 INFUSION SITE INFLAMMATION 2 0.0028
86 CERVICAL RADICULOPATHY 2 0.0028
87 INJECTION SITE HYPOAESTHESIA 4 0.0028
88 INFUSION SITE MASS 3 0.0028
89 BODY TEMPERATURE ABNORMAL 5 0.0027
90 DEVICE DEFECTIVE 47 0.0027
91 EOSINOPHIL COUNT ABNORMAL 2 0.0027
92 CHRONIC SINUSITIS 10 0.0027
93 PHARYNGEAL SWELLING 26 0.0027
94 EMERGENCY CARE 8 0.0026
95 SECRETION DISCHARGE 33 0.0026
96 ALLERGIC COUGH 2 0.0026
97 PULMONARY FUNCTION TEST ABNORMAL 4 0.0026
98 NASAL SEPTUM DEVIATION 5 0.0026
99 INCORRECT DOSE ADMINISTERED BY DEVICE 67 0.0026
100 BRONCHIAL CARCINOMA 2 0.0025
101 PNEUMONIA INFLUENZAL 3 0.0025
102 CHRONIC RESPIRATORY FAILURE 3 0.0025
103 BLOOD IMMUNOGLOBULIN G INCREASED 3 0.0025
104 BRONCHITIS CHRONIC 6 0.0025
105 INSURANCE ISSUE 37 0.0024
106 TONSILLAR HYPERTROPHY 4 0.0024
107 TONGUE COATED 4 0.0023
108 BLOOD TRIGLYCERIDES ABNORMAL 2 0.0023
109 BODY MASS INDEX INCREASED 3 0.0022
110 PNEUMONIA BACTERIAL 20 0.0022
111 HAEMOCHROMATOSIS 2 0.0022
112 LYMPH NODE PAIN 4 0.0021
113 ADVERSE FOOD REACTION 2 0.0021
114 BRONCHIAL OBSTRUCTION 3 0.0021
115 PARANASAL SINUS DISCOMFORT 8 0.0021
116 NEEDLE ISSUE 61 0.0021
117 VARICELLA 5 0.0021
118 CANCER SURGERY 2 0.0021
119 SYMPTOM RECURRENCE 12 0.0020
120 EYE ALLERGY 3 0.0019
121 INFUSION SITE DISCOMFORT 2 0.0019
122 SEASONAL ALLERGY 27 0.0019
123 DEVICE INEFFECTIVE 2 0.0019
124 COSTOCHONDRITIS 3 0.0018
125 DRUG EFFECT LESS THAN EXPECTED 27 0.0018
126 IMMUNE SYSTEM DISORDER 24 0.0018
127 UPPER-AIRWAY COUGH SYNDROME 15 0.0018
128 IMMEDIATE POST-INJECTION REACTION 2 0.0018
129 FULL BLOOD COUNT ABNORMAL 19 0.0018
130 LIQUID PRODUCT PHYSICAL ISSUE 13 0.0018
131 PHARYNGITIS 22 0.0018
132 FORCED EXPIRATORY VOLUME DECREASED 5 0.0018
133 RESPIRATORY SYMPTOM 5 0.0018
134 CHRONIC SPONTANEOUS URTICARIA 2 0.0017
135 PRODUCT DISTRIBUTION ISSUE 16 0.0017
136 DEVICE DISPENSING ERROR 2 0.0017
137 BRONCHOSPASM 24 0.0017
138 BLEEDING TIME PROLONGED 2 0.0017
139 INJECTION SITE INJURY 9 0.0016
140 BREATH SOUNDS ABNORMAL 8 0.0016
141 ANAPHYLACTIC REACTION 89 0.0016
142 DEVICE MALFUNCTION 113 0.0016
143 EOSINOPHILIC PNEUMONIA 5 0.0016
144 MOUTH SWELLING 9 0.0016
145 AORTIC ARTERIOSCLEROSIS 4 0.0016
146 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
147 PRODUCT ADMINISTRATION ERROR 31 0.0015
148 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 80 0.0015
149 BRAIN FOG 24 0.0015
150 PNEUMONIA FUNGAL 6 0.0015
151 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
152 VOCAL CORD DISORDER 3 0.0015
153 LUNG OPACITY 4 0.0015
154 THROAT TIGHTNESS 41 0.0015
155 CONJUNCTIVITIS 28 0.0015
156 ROSACEA 7 0.0015
157 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
158 SARCOIDOSIS 7 0.0015
159 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 25 0.0015
160 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 68 0.0015
161 PLEURITIC PAIN 4 0.0014
162 DISCHARGE 2 0.0014
163 ILLNESS 147 0.0014
164 EAR SWELLING 3 0.0014
165 DEVICE DEPLOYMENT ISSUE 18 0.0014
166 CHORIORETINOPATHY 2 0.0014
167 DECREASED ACTIVITY 15 0.0014
168 INFUSION SITE BRUISING 3 0.0014
169 SPUTUM INCREASED 3 0.0014
170 INJECTION SITE URTICARIA 34 0.0014
171 INJECTION SITE INDENTATION 3 0.0014
172 HENOCH-SCHONLEIN PURPURA 3 0.0014
173 RHINITIS 11 0.0014
174 CARDIAC FIBRILLATION 2 0.0014
175 INFUSION SITE INDURATION 2 0.0013
176 CHEST DISCOMFORT 138 0.0013
177 AXILLARY PAIN 2 0.0013
178 IMPETIGO 2 0.0013
179 OROPHARYNGEAL DISCOMFORT 12 0.0013
180 ARTHRALGIA 551 0.0013
181 OBESITY 21 0.0013
182 PARAESTHESIA ORAL 19 0.0013
183 INFECTIOUS PLEURAL EFFUSION 2 0.0013
184 BRONCHIAL DISORDER 2 0.0013
185 MULTIPLE ALLERGIES 10 0.0013
186 SWELLING OF EYELID 8 0.0013
187 ORTHOPNOEA 4 0.0013
188 CYSTITIS INTERSTITIAL 2 0.0012
189 ATELECTASIS 12 0.0012
190 PRODUCTIVE COUGH 59 0.0012
191 VITAMIN B12 DEFICIENCY 5 0.0012
192 HAEMATOLOGICAL INFECTION 3 0.0012
193 COUGH 342 0.0012
194 SMALL FOR DATES BABY 6 0.0012
195 PULMONARY MASS 18 0.0012
196 PRODUCT DOSE OMISSION ISSUE 355 0.0012
197 OROPHARYNGEAL PAIN 111 0.0012
198 RESPIRATORY TRACT INFECTION 31 0.0012
199 PRODUCT CONTAMINATION PHYSICAL 3 0.0012
200 INCREASED BRONCHIAL SECRETION 3 0.0012
201 PHYSICAL DECONDITIONING 3 0.0012
202 INJECTION SITE OEDEMA 2 0.0012
203 ACUTE SINUSITIS 2 0.0012
204 SPUTUM DISCOLOURED 11 0.0012
205 AORTIC STENOSIS 4 0.0011
206 DYSPNOEA 649 0.0011
207 APHONIA 16 0.0011
208 BRONCHIOLITIS 4 0.0011
209 EYE PRURITUS 38 0.0011
210 INFUSION SITE SWELLING 7 0.0011
211 MIGRAINE WITH AURA 3 0.0011
212 LUNG DISORDER 54 0.0011
213 HYPERLIPIDAEMIA 13 0.0011
214 EOSINOPHILIC OESOPHAGITIS 3 0.0011
215 OBSTRUCTIVE AIRWAYS DISORDER 12 0.0011
216 PRODUCT STORAGE ISSUE 4 0.0011
217 VIRAL INFECTION 35 0.0011
218 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
219 INTERCEPTED PRODUCT ADMINISTRATION ERROR 8 0.0010
220 BACK PAIN 242 0.0010
221 DYSPNOEA AT REST 3 0.0010
222 VITAMIN D DEFICIENCY 10 0.0010
223 EYE SWELLING 38 0.0010
224 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
225 THERAPY CHANGE 10 0.0010
226 RESPIRATION ABNORMAL 7 0.0010
227 THORACIC VERTEBRAL FRACTURE 3 0.0010
228 DYSPNOEA EXERTIONAL 38 0.0010
229 DYSPHONIA 59 0.0010
230 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
231 BLEPHARITIS 4 0.0010
232 DRUG DOSE OMISSION BY DEVICE 78 0.0010
233 ORAL CANDIDIASIS 13 0.0010
234 PULMONARY CONGESTION 13 0.0010
235 TOOTH ABSCESS 10 0.0010
236 DERMATITIS PSORIASIFORM 2 0.0010
237 HYPERPARATHYROIDISM 2 0.0010
238 INFUSION SITE PRURITUS 3 0.0009
239 TONGUE DISCOMFORT 4 0.0009
240 PNEUMONIA VIRAL 3 0.0009
241 PHARYNGITIS STREPTOCOCCAL 10 0.0009
242 DEVICE FAILURE 14 0.0009
243 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 44 0.0009
244 UPPER RESPIRATORY TRACT INFECTION 42 0.0009
245 NEAR DEATH EXPERIENCE 3 0.0009
246 SINUS DISORDER 18 0.0009
247 PNEUMONIA 294 0.0009
248 FOOD ALLERGY 7 0.0009
249 HYPERSENSITIVITY 168 0.0009
250 URTICARIA 151 0.0009
251 SLEEP APNOEA SYNDROME 17 0.0009
252 PERIORBITAL SWELLING 5 0.0009
253 INJURY ASSOCIATED WITH DEVICE 18 0.0009
254 ACCIDENTAL EXPOSURE TO PRODUCT 91 0.0009
255 DISEASE COMPLICATION 4 0.0009
256 FRUSTRATION TOLERANCE DECREASED 7 0.0009
257 HYPOAESTHESIA ORAL 13 0.0009
258 DEVICE ISSUE 77 0.0009
259 INJECTION SITE DISCOMFORT 9 0.0009
260 BRONCHITIS 63 0.0009
261 EXPOSURE VIA SKIN CONTACT 22 0.0008
262 PLEURISY 5 0.0008
263 INTENTIONAL DOSE OMISSION 24 0.0008
264 CONJUNCTIVAL HYPERAEMIA 3 0.0008
265 SINUS HEADACHE 5 0.0008
266 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
267 PYODERMA GANGRENOSUM 3 0.0008
268 INFUSION SITE ERYTHEMA 7 0.0008
269 ANOSMIA 12 0.0008
270 ADRENAL INSUFFICIENCY 10 0.0008
271 MAJOR DEPRESSION 6 0.0008
272 NASAL CONGESTION 48 0.0008
273 SINUS CONGESTION 11 0.0008
274 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
275 IMMUNODEFICIENCY 12 0.0008
276 MIDDLE INSOMNIA 15 0.0008
277 INJECTION SITE INFLAMMATION 4 0.0008
278 THROAT CLEARING 3 0.0008
279 NASAL DRYNESS 5 0.0008
280 EYE INFECTION 9 0.0008
281 EMPHYSEMA 8 0.0008
282 PARANASAL SINUS HYPERSECRETION 3 0.0008
283 THERAPEUTIC RESPONSE SHORTENED 26 0.0008
284 MYALGIA 133 0.0008
285 THYROID MASS 3 0.0008
286 PERIPHERAL VASCULAR DISORDER 4 0.0008
287 BLOOD CHLORIDE DECREASED 2 0.0008
288 MUSCULOSKELETAL CHEST PAIN 12 0.0008
289 HIATUS HERNIA 10 0.0008
290 RHINOVIRUS INFECTION 3 0.0008
291 POLYP 5 0.0008
292 PROSTATOMEGALY 3 0.0008
293 ASPERGILLUS INFECTION 5 0.0008
294 SINUSITIS 78 0.0008
295 POLYARTHRITIS 4 0.0008
296 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
297 OBSTRUCTION 3 0.0008
298 ARTERIOSPASM CORONARY 3 0.0007
299 COMPRESSION FRACTURE 4 0.0007
300 FUNGAL SKIN INFECTION 3 0.0007
301 GINGIVITIS 4 0.0007
302 PRODUCT PACKAGING ISSUE 7 0.0007
303 SKIN LACERATION 8 0.0007
304 RESPIRATORY DISORDER 22 0.0007
305 INFLUENZA 82 0.0007
306 SELF-MEDICATION 3 0.0007
307 OXYGEN SATURATION DECREASED 41 0.0007
308 ACUTE RESPIRATORY FAILURE 14 0.0007
309 THERAPY INTERRUPTED 52 0.0007
310 CHOKING SENSATION 4 0.0007
311 AORTIC DISSECTION 3 0.0007
312 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
313 AUTOIMMUNE DISORDER 7 0.0007
314 ENDOTRACHEAL INTUBATION 2 0.0007
315 THROAT IRRITATION 32 0.0007
316 INJECTION SITE PAIN 217 0.0007
317 HAND FRACTURE 5 0.0007
318 NEUROLOGICAL SYMPTOM 4 0.0007
319 PSEUDOMONAS INFECTION 6 0.0007
320 DEVICE OPERATIONAL ISSUE 3 0.0007
321 HERPES ZOSTER 40 0.0007
322 PNEUMOTHORAX 11 0.0007
323 DRY THROAT 7 0.0007
324 GASTROOESOPHAGEAL REFLUX DISEASE 55 0.0007
325 CATHETERISATION CARDIAC 3 0.0007
326 RHEUMATIC FEVER 3 0.0007
327 SUNBURN 5 0.0007
328 PNEUMONITIS 18 0.0007
329 INJECTION SITE VESICLES 4 0.0007
330 JOINT INJURY 14 0.0007
331 IMMUNE THROMBOCYTOPENIA 3 0.0007
332 HEREDITARY ANGIOEDEMA 7 0.0007
333 INJECTION SITE RASH 20 0.0007
334 MENISCUS INJURY 4 0.0006
335 RHINORRHOEA 42 0.0006
336 LYMPHADENOPATHY 23 0.0006
337 CONCUSSION 5 0.0006
338 BACTERIAL INFECTION 12 0.0006
339 EYELIDS PRURITUS 2 0.0006
340 FLANK PAIN 6 0.0006
341 BLOOD BLISTER 2 0.0006
342 VERTIGO 39 0.0006
343 TIBIA FRACTURE 3 0.0006
344 PULMONARY HAEMORRHAGE 5 0.0006
345 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
346 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
347 SKIN ABRASION 3 0.0006
348 OCULAR HYPERAEMIA 30 0.0006
349 LIP SWELLING 21 0.0006
350 SWELLING FACE 41 0.0006
351 RESPIRATORY TRACT CONGESTION 10 0.0006
352 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 113 0.0006
353 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
354 INJECTION SITE REACTION 43 0.0006
355 OCULAR DISCOMFORT 7 0.0006
356 FIBROMYALGIA 15 0.0006
357 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 4 0.0006
358 INCORRECT DISPOSAL OF PRODUCT 2 0.0006
359 COVID-19 108 0.0006
360 GOUT 11 0.0006
361 ASPHYXIA 5 0.0006
362 INFUSION SITE HAEMORRHAGE 2 0.0006
363 SPINAL COMPRESSION FRACTURE 5 0.0006
364 COLON CANCER 9 0.0006
365 ADVERSE REACTION 8 0.0006
366 MENINGITIS 4 0.0006
367 POST-TRAUMATIC STRESS DISORDER 4 0.0006
368 SENSATION OF FOREIGN BODY 5 0.0006
369 DYSLIPIDAEMIA 3 0.0006
370 INJECTION SITE HAEMORRHAGE 47 0.0006
371 DEVICE MECHANICAL ISSUE 8 0.0006
372 MUSCULOSKELETAL DISCOMFORT 10 0.0006
373 LYMPHOEDEMA 4 0.0006
374 HYPOPNOEA 2 0.0006
375 PRODUCT AVAILABILITY ISSUE 13 0.0006
376 EAR PRURITUS 2 0.0006
377 ERYTHEMA NODOSUM 2 0.0006
378 BLOOD LACTIC ACID INCREASED 3 0.0006
379 EYE PAIN 32 0.0006
380 IMMUNOSUPPRESSION 5 0.0006
381 LACRIMATION INCREASED 17 0.0006
382 INJECTION SITE SWELLING 43 0.0006
383 FEAR OF INJECTION 4 0.0006
384 PRODUCT SUPPLY ISSUE 4 0.0006
385 OVERWEIGHT 3 0.0006
386 GASTROENTERITIS VIRAL 10 0.0006
387 PULMONARY THROMBOSIS 6 0.0005
388 LIMB DISCOMFORT 17 0.0005
389 OESOPHAGITIS 6 0.0005
390 RASH 239 0.0005
391 NONSPECIFIC REACTION 3 0.0005
392 DEVICE USE ERROR 19 0.0005
393 DEAFNESS UNILATERAL 3 0.0005
394 SWOLLEN TONGUE 17 0.0005
395 CYSTIC FIBROSIS 3 0.0005
396 DIVERTICULITIS 15 0.0005
397 DRY EYE 27 0.0005
398 ARTHROPOD BITE 4 0.0005
399 HEART RATE ABNORMAL 3 0.0005
400 NODULE 7 0.0005
401 ECZEMA 28 0.0005
402 PAROSMIA 4 0.0005
403 AUTOIMMUNE THYROIDITIS 2 0.0005
404 FACE INJURY 2 0.0005
405 INFECTION 76 0.0005
406 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
407 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
408 PULMONARY FIBROSIS 10 0.0005
409 HERPES VIRUS INFECTION 3 0.0005
410 RALES 3 0.0005
411 APNOEA 4 0.0005
412 GAIT INABILITY 17 0.0005
413 ENERGY INCREASED 3 0.0005
414 RESPIRATORY DISTRESS 14 0.0005
415 HOSPICE CARE 5 0.0005
416 ACCIDENT 6 0.0005
417 EXPOSURE VIA BREAST MILK 2 0.0005
418 BLOOD DISORDER 4 0.0005
419 ATRIAL FIBRILLATION 48 0.0005
420 MIGRAINE 47 0.0005
421 PRODUCT STORAGE ERROR 43 0.0005
422 HYPERSOMNIA 14 0.0005
423 ANAPHYLACTOID REACTION 2 0.0005
424 LOWER RESPIRATORY TRACT INFECTION 22 0.0005
425 GASTROINTESTINAL PERFORATION 2 0.0005
426 SWELLING 45 0.0005
427 CONDITION AGGRAVATED 146 0.0005
428 CHEST PAIN 88 0.0005
429 INJECTION SITE IRRITATION 6 0.0005
430 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
431 DEVICE BREAKAGE 19 0.0005
432 IMPAIRED WORK ABILITY 10 0.0005
433 HAEMOGLOBIN ABNORMAL 3 0.0005
434 ANAPHYLACTIC SHOCK 12 0.0005
435 CARDIAC FLUTTER 3 0.0005
436 MUSCLE STRAIN 4 0.0005
437 HORDEOLUM 2 0.0005
438 ARTHRITIS 36 0.0005
439 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
440 EOSINOPHILIA 8 0.0005
441 JOINT SWELLING 55 0.0005
442 SPINAL OSTEOARTHRITIS 4 0.0005
443 WALKING AID USER 3 0.0005
444 INTENTIONAL DEVICE MISUSE 2 0.0005
445 GINGIVAL SWELLING 2 0.0005
446 LUNG INFILTRATION 4 0.0005
447 SKIN INFECTION 5 0.0004
448 ANAL INCONTINENCE 4 0.0004
449 TRANSIENT ISCHAEMIC ATTACK 15 0.0004
450 PANIC ATTACK 16 0.0004
451 INJECTION SITE BRUISING 35 0.0004
452 NEPHROTIC SYNDROME 3 0.0004
453 RIB FRACTURE 9 0.0004
454 INCREASED TENDENCY TO BRUISE 4 0.0004
455 NASOPHARYNGITIS 80 0.0004
456 CHRONIC MYELOID LEUKAEMIA 2 0.0004
457 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
458 PULMONARY EMBOLISM 41 0.0004
459 ARTHRITIS INFECTIVE 2 0.0004
460 FORMICATION 3 0.0004
461 THERAPY CESSATION 22 0.0004
462 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
463 THERMAL BURN 3 0.0004
464 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
465 DEAFNESS 11 0.0004
466 ENDOMETRIOSIS 2 0.0004
467 DRUG INEFFECTIVE 552 0.0004
468 CELLULITIS 21 0.0004
469 POST PROCEDURAL COMPLICATION 8 0.0004
470 PRURITUS 160 0.0004
471 PANIC REACTION 3 0.0004
472 FACE OEDEMA 7 0.0004
473 HUMERUS FRACTURE 2 0.0004
474 HEADACHE 259 0.0004
475 BURSITIS 5 0.0004
476 NECK PAIN 23 0.0004
477 UTERINE LEIOMYOMA 3 0.0004
478 CHOKING 8 0.0004
479 HORMONE LEVEL ABNORMAL 2 0.0004
480 ORAL HERPES 8 0.0004
481 DIZZINESS 204 0.0004
482 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
483 CARDIOMEGALY 5 0.0004
484 CARDIOMYOPATHY 6 0.0004
485 LIGAMENT SPRAIN 4 0.0004
486 DIABETIC NEUROPATHY 2 0.0004
487 INABILITY TO AFFORD MEDICATION 4 0.0004
488 SNEEZING 9 0.0004
489 EYE IRRITATION 23 0.0004
490 BURNING SENSATION 28 0.0004
491 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
492 CORONARY ARTERY STENOSIS 2 0.0004
493 RESPIRATORY FAILURE 29 0.0004
494 PERIPHERAL SWELLING 61 0.0004
495 OSTEOPENIA 6 0.0004
496 HAEMOPTYSIS 11 0.0004
497 TROPONIN INCREASED 3 0.0004
498 ADVERSE DRUG REACTION 35 0.0004
499 INJECTION SITE WARMTH 8 0.0004
500 INFLUENZA LIKE ILLNESS 32 0.0004
501 INFUSION SITE PAIN 5 0.0004
502 TENDONITIS 6 0.0004
503 HYPERTENSION 82 0.0004
504 CARDIAC FAILURE 31 0.0004
505 EYE DISCHARGE 4 0.0004
506 PALPITATIONS 45 0.0004
507 AFFECTIVE DISORDER 3 0.0004
508 CYANOSIS 6 0.0004
509 JOINT STIFFNESS 10 0.0004
510 BEDRIDDEN 5 0.0004
511 PAIN 233 0.0004
512 TOOTH INFECTION 5 0.0004
513 SARS-COV-2 TEST POSITIVE 5 0.0004
514 JOINT DISLOCATION 4 0.0004
515 SUDDEN DEATH 4 0.0004
516 HOSPITALISATION 58 0.0004
517 GINGIVAL PAIN 3 0.0004
518 ATRIAL FLUTTER 3 0.0004
519 EAR INFECTION 10 0.0004
520 EATING DISORDER 8 0.0004
521 ABORTION SPONTANEOUS 15 0.0004
522 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
523 INJECTION SITE PRURITUS 25 0.0004
524 ERYTHEMA OF EYELID 2 0.0004
525 HYPOXIA 13 0.0004
526 LIMB INJURY 10 0.0004
527 BIPOLAR DISORDER 4 0.0004
528 EYE DISORDER 12 0.0004
529 LUNG NEOPLASM MALIGNANT 15 0.0004
530 VISION BLURRED 50 0.0004
531 PRODUCT USE ISSUE 68 0.0004
532 EMBOLISM 3 0.0004
533 EPISTAXIS 27 0.0004
534 VENTRICULAR FIBRILLATION 4 0.0004
535 COAGULOPATHY 6 0.0004
536 FUNGAL INFECTION 12 0.0004
537 ARRHYTHMIA 17 0.0004
538 WOUND 10 0.0004
539 GASTROINTESTINAL DISORDER 32 0.0004
540 CARPAL TUNNEL SYNDROME 5 0.0004
541 KIDNEY INFECTION 7 0.0004
542 GAIT DISTURBANCE 68 0.0004
543 SKIN REACTION 5 0.0004
544 BLOOD PRESSURE ABNORMAL 7 0.0004
545 FACIAL PARALYSIS 3 0.0004
546 INJECTION SITE MASS 13 0.0004
547 FATIGUE 273 0.0004
548 RASH PRURITIC 19 0.0004
549 SCAR 6 0.0004
550 OEDEMA 19 0.0003
551 CARDIAC VALVE DISEASE 2 0.0003
552 INFLAMMATION 18 0.0003
553 CARDIAC FAILURE CONGESTIVE 28 0.0003
554 NEOPLASM 4 0.0003
555 BLOOD URIC ACID INCREASED 2 0.0003
556 PYELONEPHRITIS 3 0.0003
557 SKIN SWELLING 3 0.0003
558 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
559 HYPERVENTILATION 2 0.0003
560 TASTE DISORDER 7 0.0003
561 VASCULITIS 4 0.0003
562 HEART RATE INCREASED 34 0.0003
563 HIP FRACTURE 11 0.0003
564 NIGHT SWEATS 11 0.0003
565 PRODUCT PREPARATION ERROR 7 0.0003
566 SLEEP DISORDER 24 0.0003
567 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
568 RESPIRATORY RATE INCREASED 3 0.0003
569 BLOOD IRON DECREASED 4 0.0003
570 FACIAL PAIN 3 0.0003
571 PULMONARY OEDEMA 15 0.0003
572 RASH ERYTHEMATOUS 16 0.0003
573 THERAPY NON-RESPONDER 15 0.0003
574 INJECTION SITE ERYTHEMA 41 0.0003
575 INTERSTITIAL LUNG DISEASE 16 0.0003
576 OSTEOARTHRITIS 14 0.0003
577 NEURALGIA 8 0.0003
578 HIDRADENITIS 3 0.0003
579 DERMATITIS ACNEIFORM 2 0.0003
580 MUSCLE SPASMS 60 0.0003
581 RETINAL DETACHMENT 3 0.0003
582 SPINAL OPERATION 4 0.0003
583 SEPSIS 36 0.0003
584 INFUSION SITE EXTRAVASATION 2 0.0003
585 APPENDICITIS 3 0.0003
586 INJECTION SITE DISCOLOURATION 4 0.0003
587 BLINDNESS 13 0.0003
588 DERMATITIS ALLERGIC 4 0.0003
589 FRACTURE 6 0.0003
590 FOOT FRACTURE 6 0.0003
591 ADVERSE EVENT 29 0.0003
592 EYE INFLAMMATION 3 0.0003
593 FOREIGN BODY SENSATION IN EYES 2 0.0003
594 HYPOTHYROIDISM 10 0.0003
595 PAIN IN EXTREMITY 92 0.0003
596 MOVEMENT DISORDER 10 0.0003
597 THROMBOSIS 25 0.0003
598 MUSCLE TIGHTNESS 5 0.0003
599 EAR PAIN 6 0.0003
600 MUSCULOSKELETAL STIFFNESS 27 0.0003
601 HERPES SIMPLEX 2 0.0003
602 CEREBROVASCULAR ACCIDENT 52 0.0003
603 PLATELET COUNT INCREASED 4 0.0003
604 INFLAMMATORY BOWEL DISEASE 3 0.0003
605 VITREOUS FLOATERS 3 0.0003
606 GASTRITIS 8 0.0003
607 CORONAVIRUS INFECTION 2 0.0003
608 INCORRECT DOSE ADMINISTERED 69 0.0003
609 CARDIAC DISORDER 28 0.0003
610 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
611 MALIGNANT MELANOMA 4 0.0003
612 TOXIC SKIN ERUPTION 3 0.0003
613 BREAST MASS 2 0.0003
614 CORONARY ARTERY DISEASE 9 0.0003
615 FEELING ABNORMAL 71 0.0003
616 CANDIDA INFECTION 5 0.0003
617 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
618 ABNORMAL LOSS OF WEIGHT 2 0.0003
619 NEUTROPHIL COUNT INCREASED 3 0.0003
620 INITIAL INSOMNIA 3 0.0003
621 EAR DISCOMFORT 3 0.0003
622 BONE PAIN 17 0.0003
623 ENCEPHALITIS 2 0.0003
624 VENTRICULAR EXTRASYSTOLES 3 0.0003
625 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
626 DEMENTIA 8 0.0003
627 MASS 4 0.0003
628 FLUSHING 29 0.0003
629 CYSTITIS 9 0.0003
630 VISUAL IMPAIRMENT 35 0.0003
631 HEAD DISCOMFORT 5 0.0003
632 DRUG ERUPTION 5 0.0003
633 RETCHING 6 0.0003
634 TACHYCARDIA 25 0.0003
635 MALAISE 123 0.0003
636 ISCHAEMIC STROKE 5 0.0003
637 IRRITABLE BOWEL SYNDROME 6 0.0003
638 POOR QUALITY SLEEP 6 0.0003
639 SKIN CANCER 6 0.0003
640 MENSTRUATION DELAYED 3 0.0003
641 HYPOKINESIA 4 0.0003
642 CRYING 10 0.0003
643 RESTLESS LEGS SYNDROME 5 0.0003
644 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
645 IMPAIRED HEALING 9 0.0003
646 ANXIETY 78 0.0003
647 DYSSTASIA 8 0.0003
648 ASPIRATION 3 0.0003
649 ANGIOEDEMA 12 0.0003
650 PSORIATIC ARTHROPATHY 11 0.0003
651 FOOT DEFORMITY 3 0.0003
652 CEREBRAL DISORDER 2 0.0003
653 SKIN HAEMORRHAGE 4 0.0003
654 NEOPLASM MALIGNANT 18 0.0003
655 HYPERTENSIVE CRISIS 3 0.0003
656 RASH PAPULAR 6 0.0003
657 OSTEOPOROSIS 11 0.0003
658 TYPE 2 DIABETES MELLITUS 9 0.0003
659 HYPOAESTHESIA 40 0.0003
660 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
661 REBOUND EFFECT 3 0.0003
662 BLOOD SODIUM DECREASED 5 0.0003
663 CHILLS 31 0.0003
664 DYSPHAGIA 25 0.0003
665 DERMATITIS CONTACT 3 0.0003
666 AORTIC ANEURYSM 2 0.0003
667 CHOLECYSTECTOMY 3 0.0003
668 OEDEMA PERIPHERAL 32 0.0003
669 HAEMODYNAMIC INSTABILITY 2 0.0003
670 DIABETES MELLITUS 20 0.0003
671 MYOCARDITIS 3 0.0003
672 NEPHROLITHIASIS 12 0.0003
673 DISSOCIATION 2 0.0003
674 CONTUSION 25 0.0003
675 LYMPHOMA 4 0.0003
676 ERYTHEMA 53 0.0003
677 PYREXIA 89 0.0003
678 BASAL CELL CARCINOMA 4 0.0003
679 HEART RATE DECREASED 9 0.0003
680 SURGERY 15 0.0003
681 SKIN LESION 7 0.0003
682 COVID-19 PNEUMONIA 3 0.0003
683 MENTAL DISORDER 11 0.0003
684 BLOOD ALBUMIN DECREASED 2 0.0003
685 FEELING COLD 7 0.0003
686 POLYNEUROPATHY 3 0.0003
687 PREGNANCY 5 0.0002
688 SPINAL FRACTURE 5 0.0002
689 THYROID CANCER 3 0.0002
690 NERVOUSNESS 13 0.0002
691 SPEECH DISORDER 13 0.0002
692 MEMORY IMPAIRMENT 34 0.0002
693 THERAPEUTIC RESPONSE DECREASED 15 0.0002
694 PAIN IN JAW 7 0.0002
695 PRESYNCOPE 6 0.0002
696 RHEUMATOID ARTHRITIS 28 0.0002
697 BACK DISORDER 4 0.0002
698 BODY TEMPERATURE INCREASED 5 0.0002
699 ANGINA PECTORIS 7 0.0002
700 ABNORMAL FAECES 2 0.0002
701 HICCUPS 2 0.0002
702 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
703 ESCHERICHIA INFECTION 2 0.0002
704 TENDON RUPTURE 3 0.0002
705 GENERALISED OEDEMA 3 0.0002
706 CYST 3 0.0002
707 TOOTH EXTRACTION 3 0.0002
708 PULMONARY HYPERTENSION 5 0.0002
709 SKIN DISCOLOURATION 11 0.0002
710 TREATMENT NONCOMPLIANCE 13 0.0002
711 CARDIOVASCULAR DISORDER 6 0.0002
712 FLUID RETENTION 12 0.0002
713 ARTHROPATHY 13 0.0002
714 CARDIAC OPERATION 2 0.0002
715 ASTHENIA 87 0.0002
716 FALL 77 0.0002
717 DIPLOPIA 6 0.0002
718 MUSCULAR WEAKNESS 26 0.0002
719 GROIN PAIN 2 0.0002
720 ANKYLOSING SPONDYLITIS 3 0.0002
721 DERMATITIS ATOPIC 12 0.0002
722 LOSS OF CONSCIOUSNESS 29 0.0002
723 FEMUR FRACTURE 7 0.0002
724 HOT FLUSH 17 0.0002
725 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
726 PARAESTHESIA 35 0.0002
727 BLOOD PRESSURE INCREASED 34 0.0002
728 LEUKOCYTOSIS 4 0.0002
729 TOOTHACHE 4 0.0002
730 EXOSTOSIS 2 0.0002
731 ALOPECIA 43 0.0002
732 CATARACT 13 0.0002
733 SHOCK 5 0.0002
734 HYPERHIDROSIS 28 0.0002
735 URINARY TRACT INFECTION 37 0.0002
736 PERICARDIAL EFFUSION 5 0.0002
737 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
738 ORAL DISCOMFORT 3 0.0002
739 POLLAKIURIA 9 0.0002
740 HUNGER 3 0.0002
741 DEPRESSION 49 0.0002
742 WEIGHT DECREASED 60 0.0002
743 HEPATIC STEATOSIS 4 0.0002
744 DEATH 185 0.0002
745 ERYTHEMA MULTIFORME 2 0.0002
746 DIARRHOEA HAEMORRHAGIC 2 0.0002
747 DISCOMFORT 13 0.0002
748 PHOTOPHOBIA 4 0.0002
749 DYSARTHRIA 8 0.0002
750 FEELING HOT 13 0.0002
751 MUSCULOSKELETAL DISORDER 4 0.0002
752 NO ADVERSE EVENT 38 0.0002
753 PARALYSIS 3 0.0002
754 DRY MOUTH 17 0.0002
755 INCREASED APPETITE 4 0.0002
756 HYPOACUSIS 9 0.0002
757 MOBILITY DECREASED 15 0.0002
758 BLOOD PRESSURE FLUCTUATION 5 0.0002
759 BALANCE DISORDER 18 0.0002
760 DEPRESSED MOOD 11 0.0002
761 GLAUCOMA 4 0.0002
762 HYPERCHOLESTEROLAEMIA 2 0.0002
763 HERNIA 4 0.0002
764 DIZZINESS POSTURAL 2 0.0002
765 COELIAC DISEASE 2 0.0002
766 ACUTE MYOCARDIAL INFARCTION 6 0.0002
767 LABORATORY TEST ABNORMAL 6 0.0002
768 BODY TEMPERATURE DECREASED 2 0.0002
769 UPPER LIMB FRACTURE 4 0.0002
770 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
771 AGEUSIA 5 0.0002
772 BRAIN INJURY 2 0.0002
773 INSOMNIA 53 0.0002
774 PRODUCT PHYSICAL ISSUE 4 0.0002
775 FEEDING DISORDER 4 0.0002
776 DEVICE RELATED INFECTION 3 0.0002
777 NERVOUS SYSTEM DISORDER 6 0.0002
778 WEIGHT INCREASED 43 0.0002
779 DERMATITIS 4 0.0002
780 FOLLICULITIS 2 0.0002
781 SEIZURE 22 0.0002
782 PRODUCT USE COMPLAINT 3 0.0002
783 MOUTH ULCERATION 4 0.0002
784 NEUROPATHY PERIPHERAL 18 0.0002
785 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
786 ULCER 3 0.0002
787 ABSCESS 3 0.0002
788 BREAST PAIN 2 0.0002
789 LIVER FUNCTION TEST INCREASED 4 0.0002
790 UNEVALUABLE EVENT 14 0.0002
791 BACK INJURY 2 0.0002
792 PRODUCT PRESCRIBING ISSUE 4 0.0002
793 NAUSEA 144 0.0002
794 INJECTION SITE NODULE 2 0.0002
795 SKIN DISORDER 6 0.0002
796 TOOTH DISORDER 4 0.0002
797 URINARY RETENTION 6 0.0002
798 RASH MACULO-PAPULAR 4 0.0002
799 PERICARDITIS 3 0.0002
800 INTESTINAL PERFORATION 2 0.0002
801 HEMIPARESIS 3 0.0002
802 HEART RATE IRREGULAR 4 0.0002
803 GASTRIC HAEMORRHAGE 2 0.0002
804 MUSCLE TWITCHING 4 0.0002
805 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
806 ELECTROLYTE IMBALANCE 2 0.0002
807 EYELID OEDEMA 2 0.0002
808 MYOCARDIAL INFARCTION 30 0.0002
809 RASH MACULAR 6 0.0002
810 BRADYCARDIA 9 0.0002
811 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
812 THIRST 3 0.0002
813 DISTURBANCE IN ATTENTION 9 0.0002
814 OSTEOMYELITIS 3 0.0002
815 LOCALISED INFECTION 4 0.0002
816 MENTAL IMPAIRMENT 4 0.0002
817 BONE DISORDER 3 0.0002
818 ILL-DEFINED DISORDER 10 0.0002
819 PLEURAL EFFUSION 10 0.0002
820 SOMNOLENCE 33 0.0002
821 THINKING ABNORMAL 3 0.0002
822 HAIR COLOUR CHANGES 2 0.0002
823 PNEUMONIA ASPIRATION 4 0.0002
824 HEPATIC CIRRHOSIS 3 0.0002
825 VOMITING 75 0.0002
826 ABDOMINAL PAIN 37 0.0002
827 COLITIS 6 0.0002
828 CHRONIC KIDNEY DISEASE 12 0.0002
829 GASTRIC ULCER 3 0.0002
830 FEELING JITTERY 3 0.0002
831 TREMOR 26 0.0002
832 HYPOPHAGIA 4 0.0002
833 LOWER LIMB FRACTURE 3 0.0002
834 ERECTILE DYSFUNCTION 4 0.0002
835 ABDOMINAL PAIN UPPER 32 0.0002
836 INJECTION SITE INDURATION 2 0.0002
837 DEEP VEIN THROMBOSIS 10 0.0002
838 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
839 AMNESIA 10 0.0002
840 TINNITUS 7 0.0002
841 OSTEONECROSIS 5 0.0002
842 DISABILITY 3 0.0002
843 STAPHYLOCOCCAL INFECTION 5 0.0002
844 DEVICE DIFFICULT TO USE 10 0.0002
845 DECREASED APPETITE 35 0.0002
846 RENAL DISORDER 7 0.0002
847 SYNCOPE 15 0.0001
848 PAIN OF SKIN 4 0.0001
849 EXTRA DOSE ADMINISTERED 6 0.0001
850 FREQUENT BOWEL MOVEMENTS 4 0.0001
851 DYSKINESIA 6 0.0001
852 PRODUCT QUALITY ISSUE 20 0.0001
853 IMPAIRED GASTRIC EMPTYING 2 0.0001
854 MOOD ALTERED 4 0.0001
855 GINGIVAL BLEEDING 2 0.0001
856 CORONARY ARTERY OCCLUSION 2 0.0001
857 RESPIRATORY ARREST 4 0.0001
858 PROCEDURAL PAIN 4 0.0001
859 DELIRIUM 5 0.0001
860 BLISTER 8 0.0001
861 DEHYDRATION 19 0.0001
862 BLOOD TEST ABNORMAL 2 0.0001
863 DYSPEPSIA 14 0.0001
864 BREAST CANCER 13 0.0001
865 LETHARGY 8 0.0001
866 GASTROENTERITIS 2 0.0001
867 BLOOD PRESSURE DECREASED 9 0.0001
868 DYSGEUSIA 10 0.0001
869 COLITIS ULCERATIVE 6 0.0001
870 ABDOMINAL DISTENSION 14 0.0001
871 GLOSSODYNIA 3 0.0001
872 ORAL PAIN 3 0.0001
873 CARDIAC ARREST 11 0.0001
874 PRODUCT USE IN UNAPPROVED INDICATION 33 0.0001
875 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
876 SKIN IRRITATION 6 0.0001
877 ANKLE FRACTURE 2 0.0001
878 BLOOD CHOLESTEROL INCREASED 6 0.0001
879 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
880 COMA 6 0.0001
881 ABDOMINAL DISCOMFORT 21 0.0001
882 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
883 NEUTROPHIL COUNT DECREASED 5 0.0001
884 DRY SKIN 16 0.0001
885 BLOOD UREA INCREASED 2 0.0001
886 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
887 ABDOMINAL PAIN LOWER 3 0.0001
888 SKIN EXFOLIATION 10 0.0001
889 CIRCULATORY COLLAPSE 2 0.0001
890 SKIN ULCER 3 0.0001
891 NIGHTMARE 4 0.0001
892 ANAEMIA 22 0.0001
893 COLD SWEAT 2 0.0001
894 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
895 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
896 GALLBLADDER DISORDER 2 0.0001
897 SKIN BURNING SENSATION 8 0.0001
898 FEAR 3 0.0001
899 C-REACTIVE PROTEIN INCREASED 4 0.0001
900 HYPERGLYCAEMIA 4 0.0001
901 HYPOTENSION 22 0.0001
902 RESTLESSNESS 4 0.0001
903 BLOOD GLUCOSE ABNORMAL 2 0.0001
904 MENTAL STATUS CHANGES 3 0.0001
905 MEDICATION ERROR 6 0.0001
906 COGNITIVE DISORDER 5 0.0001
907 INTESTINAL OBSTRUCTION 4 0.0001
908 INFUSION RELATED REACTION 7 0.0001
909 HAEMORRHAGE 11 0.0001
910 DRUG INTOLERANCE 10 0.0001
911 ERUCTATION 2 0.0001
912 INTENTIONAL PRODUCT MISUSE 9 0.0001
913 HAEMORRHOIDS 2 0.0001
914 PSYCHOTIC DISORDER 3 0.0001
915 URINARY INCONTINENCE 3 0.0001
916 APHASIA 3 0.0001
917 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
918 EPILEPSY 3 0.0001
919 RENAL FAILURE 13 0.0001
920 EMOTIONAL DISORDER 3 0.0001
921 EXPOSURE DURING PREGNANCY 6 0.0001
922 CONSTIPATION 21 0.0001
923 DIARRHOEA 62 0.0001
924 ROAD TRAFFIC ACCIDENT 4 0.0001
925 HEAD INJURY 3 0.0001
926 MOOD SWINGS 3 0.0001
927 CONFUSIONAL STATE 15 0.0001
928 ACNE 7 0.0001
929 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
930 APPLICATION SITE PAIN 2 0.0001
931 OFF LABEL USE 77 0.0001
932 HAEMATURIA 3 0.0001
933 HYPOKALAEMIA 4 0.0001
934 NEOPLASM PROGRESSION 3 0.0001
935 PLATELET COUNT DECREASED 9 0.0001
936 PSORIASIS 11 0.0001
937 BLOOD GLUCOSE DECREASED 4 0.0001
938 SUICIDE ATTEMPT 5 0.0001
939 DYSURIA 3 0.0001
940 AGGRESSION 4 0.0001
941 HAEMATEMESIS 2 0.0001
942 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
943 HAEMATOMA 2 0.0001
944 PLASMA CELL MYELOMA 3 0.0001
945 SUICIDAL IDEATION 7 0.0001
946 MUSCULOSKELETAL PAIN 4 0.0001
947 DISORIENTATION 3 0.0001
948 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
949 EMOTIONAL DISTRESS 9 0.0001
950 RECTAL HAEMORRHAGE 3 0.0001
951 SEPTIC SHOCK 3 0.0001
952 IRRITABILITY 4 0.0001
953 BLOOD POTASSIUM DECREASED 2 0.0001
954 HALLUCINATION 5 0.0001
955 STOMATITIS 4 0.0001
956 GYNAECOMASTIA 2 0.0001
957 BLOOD CREATININE INCREASED 4 0.0001
958 EXPIRED PRODUCT ADMINISTERED 2 0.0001
959 ANGER 2 0.0001
960 HEPATIC ENZYME INCREASED 4 0.0001
961 BLOOD GLUCOSE INCREASED 11 0.0001
962 GASTRIC DISORDER 2 0.0001
963 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
964 PANCREATITIS 3 0.0001
965 CEREBRAL HAEMORRHAGE 2 0.0001
966 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
967 AGITATION 4 0.0001
968 HAEMATOCHEZIA 3 0.0001
969 HEPATIC FUNCTION ABNORMAL 2 0.0001
970 ABNORMAL BEHAVIOUR 2 0.0001
971 HAEMOGLOBIN DECREASED 5 0.0000
972 RENAL IMPAIRMENT 4 0.0000
973 INJURY 3 0.0000
974 HYPOGLYCAEMIA 2 0.0000
975 UNDERDOSE 3 0.0000
976 PROSTATE CANCER 3 0.0000
977 TREATMENT FAILURE 3 0.0000
978 HYPONATRAEMIA 2 0.0000
979 FLATULENCE 2 0.0000
980 ACUTE KIDNEY INJURY 5 0.0000
981 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
982 THROMBOCYTOPENIA 3 0.0000
983 DISEASE PROGRESSION 3 0.0000
984 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
985 NEUTROPENIA 3 0.0000
986 OVERDOSE 4 0.0000
987 DRUG INTERACTION 2 0.0000
988 DRUG DEPENDENCE 2 0.0000